About the company: EMBLEM, established in 1999, identifies, protects and commercializes the intellectual property developed in the EMBL world, from EMBL alumni and from non-EMBL third parties. EMBLEM currently manages a portfolio of more than 350 granted patents and patent applications, and has created 19 spin-out companies. EMBLEM facilitates and accelerates the transfer of innovative technology from basic research to industry by working closely with industrial partners spanning the biotech, IT and mechanical/electrical engineering markets and currently has more than 300 licencees of EMBL technologies.
Expertise: Identification and commercial development of life science technologies; patent and copyright protection of IP; contracting and developing collaborative research agreements. In the context of YEASTDOC, EMBLEM will provide a workshop for the ESRs that focuses on intellectual property management, technology transfer and exploitation strategies for yeast strains under development in the project.
Dr Juergen Bauer
Deputy Managing Director